blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1860438

EP1860438 - METHOD FOR IDENTIFYING TARGET PROTEIN OF AGENT AND METHOD FOR SCREENING THERAPEUTIC AGENT FOR DIABETES USING TARGET PROTEIN [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  24.09.2010
Database last updated on 20.07.2024
Most recent event   Tooltip19.10.2012Lapse of the patent in a contracting state
New state(s): TR		published on 21.11.2012  [2012/47]
Applicant(s)For all designated states
Astellas Pharma Inc.
3-11, Nihonbashi-Honcho 2-chome, Chuo-ku
Tokyo 103-8411 / JP
[2007/48]
Inventor(s)01 / ENDOH, Hideki
c/o Astellas Pharma Inc. 3-11, Nihonbashi-Honcho 2-chome Chuo-ku
Tokyo 103-8411 / JP
02 / YOKOTA, Hiroyuki
c/o Astellas Pharma Inc. 3-11, Nihonbashi-Honcho 2-chome Chuo-ku
Tokyo 103-8411 / JP
03 / HAYAKAWA, Masahiko
c/o Astellas Pharma Inc. 3-11, Nihonbashi-Honcho 2-chome Chuo-ku
Tokyo 103-8411 / JP
04 / SOGA, Shinji
c/o Astellas Pharma Inc. 3-11, Nihonbashi-Honcho 2-chome Chuo-ku
Tokyo 103-8411 / JP
 [2007/48]
Representative(s)Bates, Philip Ian
Reddie & Grose LLP The White Chapel Building
10 Whitechapel High Street
London E1 8QS / GB
[N/P]
Former [2007/48]Bates, Philip Ian
Reddie & Grose 16 Theobalds Road
London WC1X 8PL / GB
Application number, filing date06782561.209.08.2006
[2007/48]
WO2006JP315745
Priority number, dateJP2005023467312.08.2005         Original published format: JP 2005234673
JP2005027958227.09.2005         Original published format: JP 2005279582
[2007/48]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2007020853
Date:22.02.2007
Language:JA
[2007/08]
Type: A1 Application with search report 
No.:EP1860438
Date:28.11.2007
Language:EN
[2007/48]
Type: B1 Patent specification 
No.:EP1860438
Date:18.11.2009
Language:EN
[2009/47]
Search report(s)International search report - published on:JP22.02.2007
(Supplementary) European search report - dispatched on:EP14.10.2008
ClassificationIPC:G01N33/53, G01N33/15, G01N33/50, G01N33/566, C07K14/47, C12N15/09
[2007/48]
CPC:
G01N33/6803 (EP,US); A61P3/10 (EP); G01N2500/04 (EP,US);
G01N2800/042 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/48]
Extension statesRSNot yet paid
TitleGerman:VERFAHREN ZUR IDENTIFIZIERUNG DES ZIELPROTEINS EINES WIRKSTOFFS UND VERFAHREN ZUM SCREENING EINES THERAPEUTISCHEN WIRKSTOFFS GEGEN DIABETES MITTELS DES ZIELPROTEINS[2007/48]
English:METHOD FOR IDENTIFYING TARGET PROTEIN OF AGENT AND METHOD FOR SCREENING THERAPEUTIC AGENT FOR DIABETES USING TARGET PROTEIN[2007/48]
French:PROCÉDÉ SERVANT À IDENTIFIER UNE PROTÉINE CIBLE D'UN AGENT ET PROCÉDÉ SERVANT À CRIBLER UN AGENT THÉRAPEUTIQUE POUR LE DIABÈTE UTILISANT LA PROTÉINE CIBLE[2007/48]
Entry into regional phase14.09.2007Translation filed 
14.09.2007National basic fee paid 
14.09.2007Search fee paid 
14.09.2007Designation fee(s) paid 
14.09.2007Examination fee paid 
Examination procedure14.09.2007Examination requested  [2007/48]
02.12.2008Amendment by applicant (claims and/or description)
23.12.2008Despatch of a communication from the examining division (Time limit: M04)
23.04.2009Reply to a communication from the examining division
29.05.2009Communication of intention to grant the patent
07.10.2009Fee for grant paid
07.10.2009Fee for publishing/printing paid
Divisional application(s)EP09075347.6  / EP2124062
Opposition(s)19.08.2010No opposition filed within time limit [2010/43]
Fees paidRenewal fee
14.09.2007Renewal fee patent year 03
12.08.2009Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT18.11.2009
BE18.11.2009
CY18.11.2009
CZ18.11.2009
DK18.11.2009
EE18.11.2009
FI18.11.2009
LT18.11.2009
LV18.11.2009
PL18.11.2009
RO18.11.2009
SE18.11.2009
SI18.11.2009
SK18.11.2009
TR18.11.2009
BG18.02.2010
GR19.02.2010
IS18.03.2010
PT18.03.2010
HU19.05.2010
IE09.08.2010
LU09.08.2010
[2012/47]
Former [2012/44]AT18.11.2009
BE18.11.2009
CY18.11.2009
CZ18.11.2009
DK18.11.2009
EE18.11.2009
FI18.11.2009
LT18.11.2009
LV18.11.2009
PL18.11.2009
RO18.11.2009
SE18.11.2009
SI18.11.2009
SK18.11.2009
BG18.02.2010
GR19.02.2010
IS18.03.2010
PT18.03.2010
HU19.05.2010
IE09.08.2010
LU09.08.2010
Former [2012/42]AT18.11.2009
BE18.11.2009
CY18.11.2009
CZ18.11.2009
DK18.11.2009
EE18.11.2009
FI18.11.2009
LT18.11.2009
LV18.11.2009
PL18.11.2009
RO18.11.2009
SE18.11.2009
SI18.11.2009
SK18.11.2009
BG18.02.2010
GR19.02.2010
IS18.03.2010
PT18.03.2010
HU19.05.2010
IE09.08.2010
Former [2011/36]AT18.11.2009
BE18.11.2009
CY18.11.2009
CZ18.11.2009
DK18.11.2009
EE18.11.2009
FI18.11.2009
LT18.11.2009
LV18.11.2009
PL18.11.2009
RO18.11.2009
SE18.11.2009
SI18.11.2009
SK18.11.2009
BG18.02.2010
GR19.02.2010
IS18.03.2010
PT18.03.2010
IE09.08.2010
Former [2011/05]AT18.11.2009
BE18.11.2009
CY18.11.2009
CZ18.11.2009
DK18.11.2009
EE18.11.2009
FI18.11.2009
LT18.11.2009
LV18.11.2009
PL18.11.2009
RO18.11.2009
SE18.11.2009
SI18.11.2009
SK18.11.2009
BG18.02.2010
GR19.02.2010
IS18.03.2010
PT18.03.2010
Former [2010/42]AT18.11.2009
BE18.11.2009
CY18.11.2009
CZ18.11.2009
DK18.11.2009
EE18.11.2009
FI18.11.2009
LT18.11.2009
LV18.11.2009
PL18.11.2009
RO18.11.2009
SE18.11.2009
SI18.11.2009
SK18.11.2009
BG18.02.2010
IS18.03.2010
PT18.03.2010
Former [2010/31]AT18.11.2009
BE18.11.2009
CY18.11.2009
FI18.11.2009
LT18.11.2009
LV18.11.2009
PL18.11.2009
SE18.11.2009
SI18.11.2009
IS18.03.2010
PT18.03.2010
Former [2010/30]AT18.11.2009
CY18.11.2009
FI18.11.2009
LT18.11.2009
LV18.11.2009
PL18.11.2009
SE18.11.2009
SI18.11.2009
IS18.03.2010
PT18.03.2010
Former [2010/26]CY18.11.2009
FI18.11.2009
LT18.11.2009
LV18.11.2009
PL18.11.2009
SE18.11.2009
SI18.11.2009
IS18.03.2010
PT18.03.2010
Documents cited:Search[DX]WO03020963  (UNIV SYDDANSK [DK], et al) [DX] 1-6 * page 2 - page 4 * * claim 10 * * figure 3 *;
 [DX]  - HOJLUND KURT ET AL, "Proteome analysis reveals phosphorylation of ATP synthase beta-subunit in human skeletal muscle and proteins with potential roles in type 2 diabetes.", JOURNAL OF BIOLOGICAL CHEMISTRY, (20030321), vol. 278, no. 12, ISSN 0021-9258, pages 10436 - 10442, XP002494897 [DX] 1-6 * the whole document *

DOI:   http://dx.doi.org/10.1074/jbc.M212881200
 [A]  - SCHAEFER G, "SOME NEW ASPECTS ON THE INTERACTION OF HYPO GLYCEMIA PRODUCING BIGUANIDES WITH BIOLOGICAL MEMBRANES", BIOCHEMICAL PHARMACOLOGY, (1976), vol. 25, no. 18, ISSN 0006-2952, pages 2015 - 2024, XP002494898 [A] 1-6 * the whole document *

DOI:   http://dx.doi.org/10.1016/0006-2952(76)90424-X
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.